Nir Gamliel

Nir Gamliel is the Chief Business Officer at OpenDNA, a company that focuses on utilizing a cloud-based precision medicine AI platform to predict and treat complex polygenic diseases. Prior to this role, Nir served as the President and CEO at PharBeyond, a business development company in the pharmaceutical, biotechnology, and medical device fields. Nir also held positions at TikTalk, BiolineRx, BSP Biological Signal Processing, Compugen Ltd., Voltaire, and Johnson & Johnson throughout their career. Nir obtained a B.Sc. in Biology from Bar-Ilan University.